Cargando…

Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation

Matched hematopoietic stem cell transplantation (HSCT) is a feasible and curative treatment in pediatric patients with beta thalassemia major (β-TM). However, little data are available regarding patients and their parents’ health-related quality of life (HRQoL) after the procedure. As such, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulas, Olga, Efficace, Fabio, Orofino, Maria Grazia, Piroddi, Antonio, Piras, Eugenia, Vacca, Adriana, Barella, Susanna, Costa, Alessandro, Giesinger, Johannes M., La Nasa, Giorgio, Caocci, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532003/ https://www.ncbi.nlm.nih.gov/pubmed/37762987 http://dx.doi.org/10.3390/jcm12186047

Ejemplares similares

Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy
por: Caocci, Giovanni, et al.
Publicado: (2023)

Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
por: Pisu, Salvatore, et al.
Publicado: (2014)

Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
por: Caocci, Giovanni, et al.
Publicado: (2011)

What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics
por: La Nasa, Giorgio, et al.
Publicado: (2016)

Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review
por: Mulas, Olga, et al.
Publicado: (2022)

Health related quality of life in Middle Eastern children with beta-thalassemia
por: Caocci, Giovanni, et al.
Publicado: (2012)

Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials
por: Giesinger, Johannes M., et al.
Publicado: (2021)

Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
por: Sanna, Marco, et al.
Publicado: (2013)

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation
por: Mulas, Olga, et al.
Publicado: (2022)

Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
por: Mulas, Olga, et al.
Publicado: (2021)

Bone Marrow Homing and Engraftment Defects of Human Hematopoietic Stem and Progenitor Cells
por: Caocci, Giovanni, et al.
Publicado: (2017)

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis
por: Caocci, Giovanni, et al.
Publicado: (2021)

Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib?
por: Caocci, Giovanni, et al.
Publicado: (2021)

Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension
por: Mulas, Olga, et al.
Publicado: (2023)

Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia
por: Orrù, Sandro, et al.
Publicado: (2012)

Early Death in Two Patients with Acute Promyelocytic Leukemia Presenting the bcr3 Isoform, FLT3-ITD Mutation, and Elevated WT1 Level
por: Greco, Marianna, et al.
Publicado: (2013)

Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
por: Origa, Raffaella, et al.
Publicado: (2022)

Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine
por: Galitzia, Andrea, et al.
Publicado: (2022)

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
por: Caocci, Giovanni, et al.
Publicado: (2020)

Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Morelli, Emanuela, et al.
Publicado: (2021)

Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report
por: Caocci, Giovanni, et al.
Publicado: (2014)

Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript
por: Greco, Marianna, et al.
Publicado: (2013)

How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency
por: Sanna, Marco, et al.
Publicado: (2017)

Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors
por: Caocci, Giovanni, et al.
Publicado: (2020)

Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021
por: Origa, Raffaella, et al.
Publicado: (2022)

Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation
por: Caocci, Giovanni, et al.
Publicado: (2017)

First and Second Level Haemoglobinopathies Diagnosis: Best Practices of the Italian Society of Thalassemia and Haemoglobinopathies (SITE)
por: Mandrile, Giorgia, et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation and Results in Pediatric Patients with Thalassemia Major: Single-Center Study
por: Ayçiçek, Ali, et al.
Publicado: (2022)

Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
por: Rodia, R., et al.
Publicado: (2021)

Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
por: Breda, Laura, et al.
Publicado: (2012)

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
por: Efficace, Fabio, et al.
Publicado: (2022)

A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia
por: Crobu, Valeria, et al.
Publicado: (2019)

Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone
por: Carruale, Antonio, et al.
Publicado: (2020)

EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals
por: Pilz, Micha J., et al.
Publicado: (2022)

Evaluation of an automatic HPLC analyser for thalassemia and haemoglobin variants screening
por: Galanello, R., et al.
Publicado: (1995)

Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients
por: Ansari, M, et al.
Publicado: (2016)

Ruxolitinib therapy and telomere length in myelofibrosis
por: Caocci, G, et al.
Publicado: (2016)

Infection Risk Evaluation Based on a Novel Scoring System in Chronic Lymphocytic Leukemia (CLL) Patients at Diagnosis
por: Murru, Roberta, et al.
Publicado: (2022)

Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia
por: Derchi, Giorgio, et al.
Publicado: (2022)

The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: A longitudinal cohort study
por: Sancassiani, Federica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uqkicpv6c693g6d42kg34p87n9